|3 Months Ended|
Dec. 31, 2016
|Subsequent Events [Abstract]|
During the period commencing January 1, 2017 and ending on January 31, 2017 additional Series D warrants have been exercised for an aggregate issuance of 250,000 shares of the Company’s Common Stock at and exercise price of $0.25 per share, resulting in gross proceeds of $62,500. In addition, Series E warrants have been exercised for an aggregate issuance of 200,000 shares of the Company’s Common Stock at an exercise price of $0.438 per share, resulting in gross proceeds of $87,600.
The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.
No definition available.